Those patients with an elevated preoperative C-reactive protein concentration (>10 mg l−1) had a mean cancer-specific survival of 71 months compared with 96 months (P<0.001) in those patients with a C-reactive protein concentration in the normal range (⩽10 mg l−1). The gene discussed is CRP; the disease is cancer.